| Not Yet Recruiting | CD34+ Transplants for Leukemia and Lymphoma NCT05565105 | Guenther Koehne | Phase 2 |
| Recruiting | Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in NCT06904066 | National Cancer Institute (NCI) | Phase 1 |
| Not Yet Recruiting | Effectiveness and Safety of InO±DLI for Relapsed B-ALL/LBL After Allo-HSCT NCT06861348 | First Affiliated Hospital of Zhejiang University | Phase 2 |
| Completed | High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology NCT04940468 | University of Colorado, Denver | N/A |
| Unknown | Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic NCT05154474 | Weprom | — |
| Recruiting | A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1) NCT04988555 | Sumitomo Pharma America, Inc. | Phase 1 / Phase 2 |
| Unknown | CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia （ALL） NCT03544021 | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | Phase 1 / Phase 2 |
| Terminated | DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL) NCT03110354 | Daiichi Sankyo | Phase 1 |
| Terminated | Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors NCT01100658 | University of Minnesota | N/A |
| Terminated | Study of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247) NCT00907517 | Merck Sharp & Dohme LLC | Phase 1 |
| Terminated | Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical NCT01050946 | Medical College of Wisconsin | Phase 2 |
| Completed | Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia ( NCT00905034 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | NOPHO ALL-2008 Pilot Study on Consolidation Therapy for Children and Adolescents With Acute Lymphoblastic Leuk NCT00548431 | Rigshospitalet, Denmark | Phase 2 |
| Unknown | Functional Pharmacogenomics of Childhood Acute Lymphoblastic Leukemia in Taiwan NCT00526084 | National Taiwan University Hospital | — |
| Completed | Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0 NCT00406393 | Medical College of Wisconsin | Phase 3 |
| Terminated | Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor NCT00393380 | The Emmes Company, LLC | Phase 2 |
| Completed | Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malign NCT00246662 | Sunesis Pharmaceuticals | Phase 1 |
| Completed | Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL Positive NCT00763763 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Terminated | Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lympho NCT00313053 | Clare Twist | Phase 1 |
| Terminated | Post Transplant Donor Lymphocyte Infusion NCT00167180 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Completed | Randomized Double Cord Blood Transplant Study NCT00067002 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis NCT01078337 | Stanford University | — |
| Terminated | Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML) NCT00185523 | Stanford University | — |
| Terminated | Stem Cell Transplant for Hematological Malignancy NCT00176930 | Masonic Cancer Center, University of Minnesota | N/A |
| Terminated | Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies NCT00038883 | M.D. Anderson Cancer Center | N/A |
| Completed | Adult ALL Treatment at Diagnosis NCT00537550 | Gruppo Italiano Malattie EMatologiche dell'Adulto | N/A |
| Terminated | Stem Cell Transplantation for Hematological Malignancies NCT00176839 | Masonic Cancer Center, University of Minnesota | Phase 2 / Phase 3 |
| Completed | Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With M NCT00005892 | Fairview University Medical Center | N/A |
| Completed | Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia NCT00167167 | Masonic Cancer Center, University of Minnesota | N/A |
| Completed | Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III NCT00483132 | French Innovative Leukemia Organisation | Phase 3 |